生存率

结论早期诊治是提高生存率的关键，减少原发灶复发应以CT为准。

Conclusion : The key of raising survival rate was early diagnosis and treatment .

不同孵育时间及不同浓度的生存率间均有显著差异（P均0.01）。

The cell survival rate between different ALA concentration and four different incubating time and under the same incubating time with different ALA concentrations are all significant different ( P0.01 ) .

部分切除术组的3及5年生存率均比近全切除术组的低（P＜0.05）。

Partial resection gave poorer 3 - and 5 - year survivals than subtotal resection ( P0 05 ) .

结果宫颈癌Ⅱb期术中放疗组与单纯放疗组5年生存率分别是95%和88%，两组比较，差异无显著性（P>005）；

Results The 5-year survival rate in the IORT group was 95 % , and that in the single radiotherapy group 88 % .

不同分期对生存率的影响具有统计学意义（P0.05）。

The difference of tumor stage on the survival rates was statistically significant ( P0.05 ) .

利用MTT法测量出血区域细胞生存率，利用蛋白印记法检测出血区域脑组织氧化反应性蛋白及脂质氧化蛋白含量。

Cell viability , protein oxidation and lipid oxidation of the injury area were determined .

随着癌细胞核DNA含量增加，非倍体数增加，其5年生存率逐渐下降，而肿瘤复发和死亡率逐渐增高。

With nuclear DNA content increasing , the five year survival rate of the diseases decreased and the aneuploid , the recurrence rate and the mortality increased .

MT在肿瘤中的超表达与预后差相关，也与5年生存率密切相关。

The over expression of MT was closely related to poor prognosis and five year survival .

用Kaplan-Meier法算生存率，差异性用Log-Ranktest进行比较。

Survival was calculated by Kaplan-Meier method and comparison was performed using Log-rank test .

结果：第一部分：1.67例GC组织MVD与患者五年生存率呈显著负相关（P＜0.05）；

Results Part 1 : 1 . Of 67 cases of GC , MVD was negatively correlated with the 5 year survival rate .

转移性MM更是对所有的治疗策略都存在耐受，预后极差，5年生存率低，对人类造成了极大的危害。

Metastatic melanoma has a very poor prognosis and 5-year survival rate of less than 5 % , because of being largely refractory to existing therapies .

HER2和p53各级生存率曲线比较，统计学上有显著性差异，P值均小于0.01。

The survival rate curves of HER2 / p53 were significant difference in statistics between each grade ( P < 0.01 ) .

结果：单纯放疗组CR为42.5%，PR为57.5%，5年生存率为27.5%；

Results : In radiotherapy group CR was 42.5 % and PR was 57.5 % . The five-year survival rate was 27.5 % .

Ⅰ、Ⅱ、Ⅲ、Ⅳ期患者的五年生存率分别为81.5%、68.4%、41.2%、0（P0.05）。

The 5-year survival rates of stage ⅰ,ⅱ,ⅲ and ⅳ were 81.5 % , 68.4 % , 41.2 % and 0.0 % ( P0.05 ) .

RDS的发生率和生存率分别是5288%和9167%。

The occurrences of RDS and survival rates were 52.88 % and 91.67 % .

同步放化疗组CR为70.21%，PR为29.79%，5年生存率57.45%；

In radiotherapy combined with chemotherapy group CR was 70.21 % and PR was 29.79 % . The five-year survival rate was ( 57.45 % ) .

多因素分析提示，MMP鄄9表达是影响无瘤生存率的预后因素。

Multivariate analysis showed that only the expression of MMP-9 was an independent prognostic factor for disease-free survival .

生存率按照Kaplan-Meier方法计算。

The survival rate was calculated by Kaplan Meier method .

系统分析结果显示，RFA相对于PEI可提高患者的生存率并降低复发率。

System analysis results show that RFA than PEI can improve the survival rate and reduce the relapse rate .

生存率和局部控制率用KaplanMeier法计算。

Kaplan Meier method was used to calculate survival rates and local control rates of patients .

假体的生存率采用Kaplan-Meier分析，分别以髋臼、股骨假体的无菌性松动和任何原因所致的翻修为终点。

Kaplan-Meier analysis was performed to evaluate the survival of the femoral and acetabulum components .

结果手术切除＋动脉化疗组1，3，5年生存率分别为67.5%，50.0%，27.5%，明显高于其他两治疗组，P值均小于0.05。

Results The results showed that 1,3 and 5 year survival rates of surgery plus arterial chemotherapy group were 67.5 % , 50.0 % and 27.5 % which were better than the other two non-surgery group ( P < 0.05 ) .

结论早期小剂量肝素治疗可改善重症感染患者的凝血指标，减少患者在ICU的住院时间，提高其治愈率，但未能改善生存率。

Conclusions Early administration of low-dose heparin therapy can improve coagulative function in patients with severe sepsis , however , the survival rate was not improved .

PDS组A值明显低于对照组，RPE细胞生存率下降。

The A value and the survival rate of RPE cells in PDS groups was significantly lower than those in control group .

行外科切除的患者中，CS分期的Ⅰa期和TNM的Ⅰ期，3年生存率均为100%；

In patients treated with surgical resection , the CS ⅰ a group and TNM I group had a 3-year survival rate of 100 % .

生存率分析未发现各HAL组间有明显差异，且各HAL组生存率均低于NHAL组。

The survival rate of all3 HAL groups was lower than that of NHAL group .

VEGF表达阳性或MVD≥50的胃癌患者5a生存率较低（P<0.05）。

The 5 year survival rate was significantly low in GC patients with positive expression of VEGF or MVD ≥ 50 ( P < 0.05 ) .

实验结果：单因素分析表明，影响患者5年无病生存率的因素为肿瘤大小、部位、年龄、PAI-1、Ki-67和VEGF。

Results : Univariate analysis showed that the prognostic factors influencing 5-year disease-free survival were tumor size , tumor location , age , PAI-1 , Ki-67 and VEGF .

结果黄芩甙治疗组、奥曲肽治疗组12h生存率明显大于模型组，差异有显著性（P＜0.05）；

Results The 12h survival of model group was 66,67 % while those of Baicalin treatment group and Octreotide treatment groups were both 100 % , indicating a marked difference ( P < 0.05 ) .

目的分析乳腺癌术后放射治疗的效果，并观察TNM分期、术后去势及手术方法等对生存率的影响。

To analyze factors affecting survival of patients with breast cancer treated by postoperative radiotherapy , including TNM staging , castration and mode of surgery .